Search by Drug Name or NDC
NDC 00067-8140-02 EX-LAX 15 mg/1 Details
EX-LAX 15 mg/1
EX-LAX is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 00067-8140-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 00067-8140 |
|---|---|
| Product ID | 0067-8140_a062e119-cea8-49b9-b957-f17cf49157f9 |
| Associated GPIs | |
| GCN Sequence Number | 039784 |
| GCN Sequence Number Description | sennosides TAB CHEW 15 MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 12162 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Brand |
| Proprietary Name | EX-LAX |
| Proprietary Name Suffix | REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE |
| Non-Proprietary Name | SENNOSIDES |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/1 |
| Substance Name | SENNOSIDES |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M007 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00067-8140-02 (00067814002)
| NDC Package Code | 0067-8140-02 |
|---|---|
| Billing NDC | 00067814002 |
| Package | 2 PACKAGE in 1 BOX (0067-8140-02) / 12 TABLET, CHEWABLE in 1 PACKAGE |
| Marketing Start Date | 2017-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |